OTC Healthcare in the Netherlands
Euromonitor International's OTC Healthcare in the Netherlands market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 88 | Publication date: Jun 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Good growth levels achieved in the Dutch OTC healthcare industry in 2005
Of all the various ranges within the OTC healthcare industry, vitamins and dietary supplements showed the strongest performance in 2005, continuing previous trends. Cold, cough and allergy (hay fever) remedies also had a good year, helped by poor weather conditions that included an extremely wet summer. A solid performance was also enjoyed by child-specific OTC healthcare, albeit from a low base as only relatively few products specially formulated for children are found in the Netherlands. Sales of analgesics suffered from the rise in importance of private label and because consumers looked for alternatives. Aspirin for instance, performed particularly poorly. Increasingly busy lifestyles led to increased sales in some ranges, most notably calming and sleeping products, and digestive remedies, owing to changing eating patterns.
Industry led by handful of players
The OTC healthcare industry is led by a handful of manufacturers, although there are also multiple small players that specialise in certain niche areas. Many manufacturers faced increasing competition in 2005, prompting some companies to make acquisitions to improve their industry share, whilst others chose to exit. Perhaps the most important acquisition is that of Bayer, which agreed to acquire Roche Consumer Health, the OTC division of Roche Nederland. This was effective as of January 2006. Boots, the fourth most important player, was sold to Reckitt Benckiser during 2005 owing to price competition, especially from private label. Viatris was acquired by the Swedish pharmaceutical concern Meda in 2005 and Apothekers Coöperatie exited the OTC healthcare industry in 2005 to concentrate on prescription-only sales.
Price wars spill over into the OTC retail distribution structure
From the end of 2003, price wars were apparent between retail outlets in the Netherlands, leading to severe price reductions. Starting in grocery outlets, these wars spilled over into other areas of retailing during 2005. Drugstores/parapharmacies maintained its lead in sales of OTC products, whilst chemists/pharmacies continued to lose share, even although this channel is making tremendous efforts to refresh the image of its outlets as well as its private label offerings. However, owing to lower prices, grocery outlets is seeing an increase in its industry share of OTC healthcare products, putting further pressure on traditional outlets.
Private label products eroding shares of leading brands
The penetration of private label has grown across the entire Dutch OTC healthcare industry, reversing declines seen over the last couple of years of the review period. This is being helped by the leading drugstores, which are refreshing and expanding their offerings and premises, and by grocery outlets, some of which are also experimenting with private label. Not only are brand sales being eroded, but the increase in private label is driving down prices
Lower growth expected for the forecast period
Owing to on-going price pressures and the maturity of some ranges within the OTC healthcare industry, vitamins and dietary supplements will continue to perform well throughout the forecast period. Child-specific OTC healthcare and calming and sleeping products will also perform well, and cold remedies is expected to demonstrate healthy sales, although this will be highly dependent on weather patterns. Lacklustre growth is likely in most other ranges.
Table of contents
OTC HEALTHCARE IN THE NETHERLANDS : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Table 9 Penetration of Private Label by Sector 2001-2005
Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
LOCAL COMPANY PROFILES - NETHERLANDS
BAYER BV - OTC HEALTHCARE - NETHERLANDS
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Bayer BV: Operational Indicators 2004
PRODUCTION CAPACITY
BIONAL PHARMA BV - OTC HEALTHCARE - NETHERLANDS
COMPANY BACKGROUND
RECENT NEWS
Summary 2 Summary - Bional: Operational Indicators 2004
PRODUCTION CAPACITY
CHEFARO INTERNATIONAL BV - OTC HEALTHCARE - NETHERLANDS
COMPANY BACKGROUND
RECENT NEWS
Summary 3 Summary - Chefaro International BV: Operational Indicators 2004
PRODUCTION CAPACITY
VIATRIS BV - OTC HEALTHCARE - NETHERLANDS
COMPANY BACKGROUND
RECENT NEWS
Summary 4 Summary - Viatris BV: Operational Indicators 2004
PRODUCTION CAPACITY
ANALGESICS IN THE NETHERLANDS
SECTOR PERFORMANCE
2005 headlines
Private label dents sales of analgesics
Leaders increase their share
Adult analgesics continues to be the most important, although growth is slowing
Child-specific analgesics witnesses declining growth rates
Topical analgesics/anaesthetic continues to witness the strongest value growth
Forecast performance
Table 12 Sales of Analgesics by Subsector: Value 2000-2005
Table 13 Sales of Analgesics by Subsector: % Value Growth 2000-2005
Table 14 Analgesics Company Shares by Retail Value 2001-2005
Table 15 Analgesics Brand Shares by Retail Value 2002-2005
Table 16 Forecast Sales of Analgesics by Subsector: Value 2005-2010
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT
Table 18 Herbal vs Standard Topical Analgesics 2000/2005
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE NETHERLANDS
SECTOR PERFORMANCE
2005 headlines
Poor weather in 2005 boosts sales
Medicated confectionery remains most valuable range within cough, cold and allergy (hay fever) remedies
Decongestants falling out of favour
Cough remedies continues to slide
Growth of child-specific cough, cold and allergy remedies begins to fall
Importance of medicated confectionery reflected in leading brands
Private label picking up strongly
Forecast performance
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
Table 21 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
Summary 5 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
DECONGESTANTS PERFORMANCE
Table 26 Sales of Decongestants by Type: Value 2000-2005
Table 27 Sales of Decongestants by Type: % Value Growth 2000-2005
CHILD-SPECIFIC COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES PERFORMANCE
Table 28 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2000-2005
Table 29 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2000-2005
DIGESTIVE REMEDIES IN THE NETHERLANDS
SECTOR PERFORMANCE
2005 headlines
Sales of digestive remedies continue to slow down
Self-selection key to driving sales
Indigestion and heartburn remedies accounts for the majority of value sales of digestive remedies
Motion sickness remedies underperforms
Sales of child-specific digestive remedies barely exist
Forecast performance
Table 30 Sales of Digestive Remedies by Subsector: Value 2000-2005
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2000-2005
Table 32 Digestive Remedies Company Shares by Retail Value 2001-2005
Table 33 Digestive Remedies Brand Shares by Retail Value 2002-2005
Summary 6 Summary - Digestive Remedies: New Product Launches 2004-2005
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2005-2010
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2005-2010
DIGESTIVE REMEDIES BY HERBAL/STANDARD SPLIT
Table 36 Herbal vs Standard Digestive Remedies 2000/2005
OTHER INDIGESTION AND HEARTBURN REMEDIES PERFORMANCE
Table 37 Sales of Other Indigestion and Heartburn Remedies by Type: Value 2000-2005
Table 38 Sales of Other Indigestion and Heartburn Remedies by Type: % Value Growth 2000-2005
MEDICATED SKIN CARE IN THE NETHERLANDS
SECTOR PERFORMANCE
2005 headlines
Medicated skin care highly fragemented and in decline
Only lip care treatments shows real dynamism
Sales of topical germicidals/anticeptics and antipruritics dips in 2005
Child-specific medicated skin care products show growth
Declining growth for acne treatments
Other products have only minor sales
Forecast performance
Table 39 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 40 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 41 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 42 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Summary 7 Summary - Medicated Skin Care: New Product Launches 2004-2005
Table 43 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 44 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
Table 45 Herbal vs Standard Medicated Skin Care 2000/2005
ACNE TREATMENTS BRAND SHARES
Table 46 Acne Treatments Brand Shares by Retail Value 2002-2005
HAIR LOSS TREATMENTS BRAND SHARES
Table 47 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
VITAMINS AND DIETARY SUPPLEMENTS IN THE NETHERLANDS
SECTOR PERFORMANCE
2005 headlines
Most dynamic product group within the Dutch OTC healthcare industry
Lifestyle concerns fuel sales
Vitamins remains the most popular range
Sales of dietary supplements witness rapid growth
Dip in performance of child-specific vitamins and dietary supplements
Three main players control value sales
Forecast performance
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2000-2005
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2000-2005
Table 50 Vitamins and Dietary Supplements Company Shares by Retail Value 2001-2005
Table 51 Vitamins and Dietary Supplements Brand Shares by Retail Value 2002-2005
Summary 8 Summary - Vitamins and Dietary Supplements: New Product Launches 2004-2005
Table 52 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2005-2010
Table 53 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2005-2010
VITAMINS PERFORMANCE
Vitamins growth falling, but still high
Multivitamins maintains its performance
Products become more tied to lifestyle
Single vitamins less popular than multivitamins
Vitamin C most popular
Vitamin D and E sales have shown strong growth
Chained drugstores/parapharmacies expand the most rapidly
Three manufacturers control sales
Table 54 Sales of Vitamins by Type: Value 2000-2005
Table 55 Sales of Vitamins by Type: % Value Growth 2000-2005
Table 56 Vitamins Brand Shares by Retail Value 2002-2005
DIETARY SUPPLEMENTS PERFORMANCE
Strong performance from dietary supplements
Growth spurred by health and wellness concerns
Private label performs well
Garlic remains the most valuable range
Products for warding off seasonal illnesses perform well
Growth seen in supplements for the elderly
Traditional ranges see least growth
Table 57 Sales of Dietary Supplements by Type: Value 2000-2005
Table 58 Sales of Dietary Supplements by Type: % Value Growth 2000-2005
Table 59 Dietary Supplements Brand Shares by Retail Value 2002-2005
Table 60 Dietary Supplements by Positioning: % Retail Value Analysis 2005
NRT SMOKING CESSATION AIDS IN THE NETHERLANDS
NUMBER OF SMOKERS
Table 61
SECTOR PERFORMANCE
2005 headlines
Low growth and low level of sales for NRT smoking cessation aids
Low levels of usage of NRT smoking cessation aids results in stagnating growth
NRT gum and NRT patches only viable products
Novartis clear leader in NRT smoking cessation aids
Forecast performance
Table 62 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 63 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 64 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 65 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Summary 9 Summary - NRT Smoking Cessation Aids: New Product Launches 2004-2005
Table 66 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 67 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
EYE CARE IN THE NETHERLANDS
SECTOR PERFORMANCE
2005 headlines
Lacklustre performance in eye care
Consumers seek specialist advice in eye care
Eye care controlled by just one manufacturer
Forecast performance
Table 68 Sales of Eye Care by Subsector: Value 2000-2005
Table 69 Sales of Eye Care by Subsector: % Value Growth 2000-2005
Table 70 Eye Care Company Shares by Retail Value 2001-2005
Table 71 Eye Care Brand Shares by Retail Value 2002-2005
Table 72 Forecast Sales of Eye Care by Subsector: Value 2005-2010
Table 73 Forecast Sales of Eye Care by Subsector: % Value Growth 2005-2010
EAR CARE IN THE NETHERLANDS
SECTOR PERFORMANCE
Ear care sales minimal
ADULT MOUTHCARE IN THE NETHERLANDS
SECTOR PERFORMANCE
Sales of adult mouthcare restricted in nature
CALMING AND SLEEPING PRODUCTS IN THE NETHERLANDS
SECTOR PERFORMANCE
Calming and sleeping products appeal to busy consumers
WOUND TREATMENTS IN THE NETHERLANDS
SECTOR PERFORMANCE
2005 headlines
Prices under pressure in 2005
Sticking plasters most important in terms of sales
Child-specific products important in the sales mix
Lower growth seen in specialist treatments
Beiersdorf dominates sales
Forecast performance
Table 74 Sales of Wound Treatments by Subsector: Value 2000-2005
Table 75 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
Table 76 Wound Treatments Company Shares by Retail Value 2001-2005
Table 77 Wound Treatments Brand Shares by Retail Value 2002-2005
Table 78 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
Table 79 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
EMERGENCY CONTRACEPTION IN THE NETHERLANDS
SECTOR PERFORMANCE
Emergency contraception introduced to OTC healthcare industry